Italy Fill-finish Pharmaceutical Contract Manufacturing Market Size & Outlook

The fill-finish pharmaceutical contract manufacturing market in Italy is expected to reach a projected revenue of US$ 280.1 million by 2030. A compound annual growth rate of 5.7% is expected of Italy fill-finish pharmaceutical contract manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$190.3
Forecast, 2030 (US$M)
$280.1
CAGR, 2024 - 2030
5.7%
Report Coverage
Italy

Italy fill-finish pharmaceutical contract manufacturing market, 2018-2030 (US$M)

Italy

Related Markets

Italy fill-finish pharmaceutical contract manufacturing market highlights

  • The Italy fill-finish pharmaceutical contract manufacturing market generated a revenue of USD 190.3 million in 2023 and is expected to reach USD 280.1 million by 2030.
  • The Italy market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
  • In terms of segment, large molecules was the largest revenue generating molecule type in 2023.
  • Small molecules is the most lucrative molecule type segment registering the fastest growth during the forecast period.


Fill-finish pharmaceutical contract manufacturing market data book summary

Market revenue in 2023USD 190.3 million
Market revenue in 2030USD 280.1 million
Growth rate5.7% (CAGR from 2023 to 2030)
Largest segmentLarge molecules
Fastest growing segmentSmall molecules
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationLarge Molecules, Small molecules
Key market players worldwideBoehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International


Other key industry trends

  • In terms of revenue, Italy accounted for 2.0% of the global fill-finish pharmaceutical contract manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany fill-finish pharmaceutical contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 822.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Fill-finish Pharmaceutical Contract Manufacturing Market Companies

Name Profile # Employees HQ Website

Italy fill-finish pharmaceutical contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.


Large molecules was the largest segment with a revenue share of 67.1% in 2023. Horizon Databook has segmented the Italy fill-finish pharmaceutical contract manufacturing market based on large molecules, small molecules covering the revenue growth of each sub-segment from 2018 to 2030.


The fill-finish pharmaceutical contract manufacturing industry in Italy is growing with several companies offering these services. Fill-finish manufacturing refers to the final stages of the drug manufacturing process, which involves filling the drug into containers, such as vials or syringes, and finishing it with labeling & packaging.

The COVID-19 pandemic has had an impact on the fillfinish pharmaceutical contract manufacturing scenario in Italy, as many companies have been increasing the production of vaccines and therapeutics. Some Italian CMOs have been involved in the production of COVID-19 vaccines, such as Stevanato Group, which has partnered with several vaccine developers to provide fill-finish services.

Moreover, the growing demand for the production of biologics and biosimilars in Italy is also one of the primary drivers of the market. The Italian government has implemented policies that support the growth of pharmaceutical companies that produce biologics and biosimilars. In 2018, the Italian Ministry of Health funded a 4-year project named Assessment of short- and long-term risk−benefit profiles of biologicals through a healthcare database network in Italy.

Reasons to subscribe to Italy fill-finish pharmaceutical contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Italy fill-finish pharmaceutical contract manufacturing market databook

  • Our clientele includes a mix of fill-finish pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Italy fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Italy fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Italy fill-finish pharmaceutical contract manufacturing market size, by molecule type, 2018-2030 (US$M)

Italy Fill-finish Pharmaceutical Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

Italy fill-finish pharmaceutical contract manufacturing market size, by molecule type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more